Intriguingly, oncogenic MYCN in neuroblastoma cells also drives compensatory mechanisms to suppress ferroptosis, including induction of GSH synthesis (via GCLC) and an elevated usage of the transsulfuration pathway mediating methionine to cysteine conversion via CBS [244]. This evidence concerns the gene MYCN and neuroblastoma.